These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16186248)

  • 1. Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA.
    Kohlstedt K; Kellner R; Busse R; Fleming I
    Mol Pharmacol; 2006 Jan; 69(1):19-26. PubMed ID: 16186248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
    Kohlstedt K; Brandes RP; Müller-Esterl W; Busse R; Fleming I
    Circ Res; 2004 Jan; 94(1):60-7. PubMed ID: 14615289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
    Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
    Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CK2 phosphorylates the angiotensin-converting enzyme and regulates its retention in the endothelial cell plasma membrane.
    Kohlstedt K; Shoghi F; Müller-Esterl W; Busse R; Fleming I
    Circ Res; 2002 Oct; 91(8):749-56. PubMed ID: 12386153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function.
    Li Y; Friedmann DR; Mhatre AN; Lalwani AK
    Cell Motil Cytoskeleton; 2008 May; 65(5):393-405. PubMed ID: 18330899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of non-muscle type myosin heavy polypeptide 9 (MYH9) in mammalian cells.
    Takubo T; Wakui S; Daigo K; Kurokata K; Ohashi T; Katayama K; Hino M
    Eur J Histochem; 2003; 47(4):345-52. PubMed ID: 14706930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells.
    Kohlstedt K; Busse R; Fleming I
    Hypertension; 2005 Jan; 45(1):126-32. PubMed ID: 15569856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.
    Kohlstedt K; Gershome C; Trouvain C; Hofmann WK; Fichtlscherer S; Fleming I
    Mol Pharmacol; 2009 Mar; 75(3):685-92. PubMed ID: 19114589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells.
    Lavrentyev EN; Estes AM; Malik KU
    Circ Res; 2007 Aug; 101(5):455-64. PubMed ID: 17626897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling by the angiotensin-converting enzyme.
    Fleming I
    Circ Res; 2006 Apr; 98(7):887-96. PubMed ID: 16614314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE activity affects myogenic differentiation via mTOR signaling.
    Mori S; Tokuyama K
    Biochem Biophys Res Commun; 2007 Nov; 363(3):597-602. PubMed ID: 17892857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmuscle myosin IIA is required for lamellipodia formation through binding to WAVE2 and phosphatidylinositol 3,4,5-triphosphate.
    Morimura S; Suzuki K; Takahashi K
    Biochem Biophys Res Commun; 2011 Jan; 404(3):834-40. PubMed ID: 21184743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinins, receptors, kininases and inhibitors--where did they lead us?
    Erdös EG; Marcic BM
    Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of MYH9 expression by short hairpin RNA expression vector in human umbilical vein endothelial cells (HUVEC)].
    Huang YL; Kou JP; Song JX; Yu BY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1160-3. PubMed ID: 19068200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol ester-induced juxtamembrane cleavage of angiotensin-converting enzyme is not inhibited by a stalk containing intrachain disulfides.
    Schwager SL; Chubb AJ; Scholle RR; Brandt WF; Eckerskorn C; Sturrock ED; Ehlers MR
    Biochemistry; 1998 Nov; 37(44):15449-56. PubMed ID: 9799507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
    Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
    Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.
    Woodman ZL; Oppong SY; Cook S; Hooper NM; Schwager SL; Brandt WF; Ehlers MR; Sturrock ED
    Biochem J; 2000 May; 347 Pt 3(Pt 3):711-8. PubMed ID: 10769174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYH9-related platelet disorders.
    Althaus K; Greinacher A
    Semin Thromb Hemost; 2009 Mar; 35(2):189-203. PubMed ID: 19408192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope-dependent blocking of the angiotensin-converting enzyme dimerization by monoclonal antibodies to the N-terminal domain of ACE: possible link of ACE dimerization and shedding from the cell surface.
    Kost OA; Balyasnikova IV; Chemodanova EE; Nikolskaya II; Albrecht RF; Danilov SM
    Biochemistry; 2003 Jun; 42(23):6965-76. PubMed ID: 12795591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
    Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
    Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.